|
Polymorphisms in adipokine-related genes to predict treatment outcomes in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab-based chemotherapy. |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Bayer; Merck KGaA; Roche; Sanofi; Sirtex Medical |
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Merck KGaA; Roche; Sanofi |
Travel, Accommodations, Expenses - Amgen; Bayer; Merck KGaA; Roche; Sanofi; Sirtex Medical |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - bioTheranostics; Merrion |
|
|
Honoraria - Bayer; Chugai Pharma; Merck; Taiho Pharmaceutical |
Research Funding - Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha |
|
|
Honoraria - Amgen; Baxalta; Celgene; Merck; Roche; Sanofi; Sirtex Medical |
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Merck; Roche; Sanofi; Sirtex Medical |
Research Funding - Amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); IntegraGen (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Sirtex Medical (Inst); Taiho Pharmaceutical (Inst) |
Travel, Accommodations, Expenses - Amgen; Baxalta; Merck; Roche; Sirtex Medical |
|
|
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche |
Consulting or Advisory Role - Bayer; Merck Serono; Roche |
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche |